VMD
Viemed Healthcare Inc.
$6.46
+$0.07(+1.10%)
53
Overall
75
Value
36
Tech
50
Quality
Market Cap
$261.03M
Volume
160.66K
52W Range
$5.93 - $9.81
Target Price
$15.00
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Total Revenue | $46.9M | $64.5M | $80.3M | $131.3M | $117.1M | $138.8M | $183.0M | $224.3M | ||
| Total Revenue | $46.9M | $64.5M | $80.3M | $131.3M | $117.1M | $138.8M | $183.0M | $224.3M | ||
| COST OF GOODS SOLD | ||||||||||
| Cost of Revenue | $12.3M | $16.7M | $24.3M | $51.2M | $43.7M | $54.2M | $70.2M | $91.1M | ||
| GROSS PROFIT | ||||||||||
| Gross Profit | $34.6M | $47.8M | $56.0M | $80.1M | $73.4M | $84.7M | $112.8M | $133.2M | ||
| OPERATING EXPENSES | ||||||||||
| Operating Expenses | $20.6M | $37.6M | $46.8M | $55.7M | $61.4M | $77.1M | $98.0M | $117.2M | ||
| Research & Development | -- | -- | $848.0K | $1.1M | $2.1M | $2.7M | $2.8M | $3.1M | ||
| Research Expense | -- | -- | -- | -- | -- | $2.7M | $2.8M | $3.1M | ||
| Selling, General & Administrative | $20.2M | $37.0M | $45.3M | $57.7M | $60.0M | $68.2M | $87.9M | $106.2M | ||
| Selling & Marketing Expenses | $162.0K | $268.0K | -- | -- | -- | $68.2M | $87.9M | $106.2M | ||
| General & Administrative Expenses | $20.1M | $37.0M | $45.3M | $57.7M | $60.0M | -- | -- | -- | ||
| Salaries & Wages | $14.9M | $2.7M | $3.9M | $4.9M | $5.2M | $5.2M | $5.8M | $6.3M | ||
| Depreciation & Amortization | $402.0K | $588.0K | $671.0K | $816.0K | $851.0K | $1.0M | $1.4M | $1.5M | ||
| Depreciation & Amortization | $402.0K | $588.0K | $671.0K | $816.0K | $851.0K | $1.0M | $1.4M | $1.5M | ||
| Other Operating Expenses | -- | -- | $3.0K | $-4.0M | $-1.6M | -- | $98.0K | $173.0K | ||
| OPERATING INCOME | ||||||||||
| Operating income | $14.0M | $10.2M | $9.2M | $24.5M | $12.0M | $7.6M | $14.8M | $16.0M | ||
| EBITDA | -- | -- | -- | -- | -- | $24.6M | $36.8M | $42.5M | ||
| NON-OPERATING ITEMS | ||||||||||
| Interest Expense (Non-Operating) | $272.0K | $181.0K | $314.0K | $509.0K | $318.0K | $197.0K | $424.0K | $776.0K | ||
| Net Non-Operating Interest Income/Expense | $272.0K | $181.0K | $314.0K | $509.0K | $318.0K | $-197.0K | $-424.0K | $-776.0K | ||
| Gain on Sale of Securities | $-158.0K | $-205.0K | $363.0K | -- | -- | -- | $-485.0K | $-954.0K | ||
| Other Income/Expense | $-5.5M | $-330.0K | $-107.0K | $2.4M | $793.0K | $-1.6M | $-160.0K | $-951.0K | ||
| Other Special Charges | -- | -- | -- | -- | -- | $989.0K | $98.0K | -- | ||
| SPECIAL ITEMS | ||||||||||
| Special Income Charges | $5.3M | $125.0K | $473.0K | $-2.3M | $448.0K | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||
| EBIT | $7.9M | $9.5M | $8.5M | $25.9M | $12.2M | $9.0M | $14.9M | $16.9M | ||
| Pre-Tax Income | $8.2M | $9.7M | $8.8M | $26.4M | $12.5M | $9.0M | $14.5M | $16.2M | ||
| INCOME TAX | ||||||||||
| Tax Provision | $15.0K | $162.0K | $271.0K | $-5.2M | $3.4M | $2.8M | $-4.1M | $4.8M | ||
| NET INCOME | ||||||||||
| Net Income | $8.2M | $9.5M | $8.5M | $31.5M | $9.1M | $6.2M | $18.7M | $11.3M | ||
| Net Income (Continuing Operations) | $8.2M | $9.5M | $8.5M | $31.5M | $9.1M | $6.2M | $18.7M | $11.4M | ||
| Net Income (Discontinued Operations) | $8.2M | $9.5M | $8.5M | $31.5M | $9.1M | $6.2M | $18.7M | $11.3M | ||
| Net Income (Common Stockholders) | $8.2M | $9.5M | $8.5M | $31.5M | $9.1M | $6.2M | $18.7M | $11.3M | ||
| Normalized Income | $-208.9M | $-246.6M | $-224.3M | $21.2M | -- | $7.0M | $9.7M | $14.1M | ||
| TOTALS | ||||||||||
| Total Expenses | $-33.0M | $-54.3M | $-71.0M | $-106.9M | $-105.0M | $131.2M | $168.2M | $208.3M | ||
| SHARE & EPS DATA | ||||||||||
| Average Shares Outstanding | $37.9M | $37.9M | $37.7M | $38.7M | $39.5M | $38.7M | $38.4M | $38.8M | ||
| Average Shares Outstanding (Diluted) | $38.0M | $39.7M | $39.7M | $40.5M | $40.7M | $39.8M | $40.4M | $40.8M | ||
| Shares Outstanding | $37.9M | $37.5M | $38.0M | $39.1M | $39.6M | $39.6M | $39.6M | $39.6M | ||
| Basic EPS | $0.22 | $0.25 | $0.23 | $0.81 | $0.23 | $0.16 | $0.27 | $0.29 | ||
| Basic EPS (Continuing Operations) | $0.22 | $0.25 | $0.23 | $0.81 | $0.23 | $0.16 | $0.27 | $0.29 | ||
| Diluted EPS | $0.22 | $0.24 | $0.21 | $0.78 | $0.22 | $0.16 | $0.25 | $0.28 | ||
| Diluted EPS (Continuing Operations) | $0.22 | $0.24 | $0.21 | $0.78 | $0.22 | $0.16 | $0.25 | $0.28 | ||
| OTHER METRICS | ||||||||||
| Earnings from equity interest | -- | -- | $-110.0K | $91.0K | $1.2M | $935.0K | $485.0K | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | $-110.0K | $91.0K | $1.2M | $935.0K | $485.0K | -- | ||
| Gain On Sale Of P P E | $-203.0K | $-54.0K | $-360.0K | $2.3M | $-448.0K | $-346.0K | $645.0K | $1.9M | ||
| Insurance And Claims | $240.0K | $316.0K | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | -- | -- | -- | -- | -- | -- | -- | $-144.0K | ||
| Net Operating Interest Income Expense | -- | -- | -- | -- | -- | $-197.0K | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | $54.2M | $70.2M | $91.1M | ||
| Other Gand A | $20.1M | $37.0M | $45.3M | $57.7M | $60.0M | -- | -- | -- | ||
| Write Off | $5.1M | $6.2M | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | $71.0K | $113.0K | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VMD | $6.46 | +1.1% | 160.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |